ABT · Transaction Jul 30, 2026 · Filed Aug 14, 2026 · $1,001 to $15,000
XNYS · ABT
+0.67% · +$0.7400 · Vol Not reported
Pre-market · updated 04:00:50 ET
Abbott Laboratories
PHARMACEUTICAL PREPARATIONS
$111.21
Veridion Score
BETAHIGH CONF · 6 of 6 factors measuredWed Sep 2 · last completed session · Pre-market · regular session opens 9:30 ET · ABT
MethodologyABT
Abbott Laboratories
Wed Sep 2 · last completed session · Pre-market · regular session opens 9:30 ET
Highest qualified
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
76/ 100
Veridion Score
Highest qualified · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Wed Sep 2 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ABT moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Abbott Laboratories
PHARMACEUTICAL PREPARATIONSListed since
1949
Employees
115K
Country
US
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$110.47
Last session
Day high
$110.47
Last session
Day low
$110.47
Last session
Previous close
$110.47
52W high
$136.62
-18.60% from high
52W low
$82.56
53% of range
Market cap
$191.2B
P/E
38.22×
EPS
$2.91
Beta
-0.44
Shares out
1.7B
Avg volume
8.4M
VWAP
$110.47
Last session
Price history computed in-house
1W
-0.34%
1M
+5.45%
3M
+22.11%
1Y
-15.86%
YTD
-11.24%
SMA 50 $103.71 · above
SMA 200 $106.52 · above
52W position 53%
ABT overview
Veridion Score
76
Registered · 2026-09-02
6 of 6 factors measured
Latest receipt rows
5
Richard McCormick · Sale
13F holders
1
Two Sigma Investments, LP
Receipt-backed holder profiles
SEC industry peers
ABT peers
Related filings and maps
Public disclosures
Congress activity in ABT
Official filing ↗
Abbott Laboratories Common Stock · Transaction Jul 30, 2026 · Filed Aug 14, 2026 · $1,001 to $15,000
Abbott Laboratories Common Stock · Transaction Jul 17, 2026 · Filed Aug 12, 2026 · $1,001 to $15,000
Abbott Laboratories Common Stock · Transaction Jul 14, 2026 · Filed Aug 18, 2026 · $15,001 to $50,000
Rick LarsenSell
ABT · Transaction Jul 8, 2026 · Filed Jul 12, 2026 · $1,001 to $15,000
Federal contracts
ABT contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ABT in this window.
Lobbying spend
ABT lobbying filings, year to date.
Registered lobbying filings matched to Abbott Laboratories.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ABT in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ABT.
Options
Sovereign unlock shows live options positioning for ABT.